ISCOTIN

Iscotin Adverse Events Reported to the FDA Over Time

How are Iscotin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Iscotin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Iscotin is flagged as the suspect drug causing the adverse event.

Most Common Iscotin Adverse Events Reported to the FDA

What are the most common Iscotin adverse events reported to the FDA?

Hepatic Function Abnormal	23 (2.8%)
Aspartate Aminotransferase Increase...	19 (2.31%)
Condition Aggravated	17 (2.07%)
Liver Disorder	17 (2.07%)
Alanine Aminotransferase Increased	16 (1.95%)
Disseminated Intravascular Coagulat...	16 (1.95%)
Hepatitis B	16 (1.95%)
Hepatorenal Syndrome	12 (1.46%)
Malaise	12 (1.46%)
Pneumocystis Jiroveci Pneumonia	11 (1.34%)
Pyrexia	10 (1.22%)
	Show More
Sepsis	10 (1.22%)
White Blood Cell Count Decreased	10 (1.22%)
Hepatitis Acute	9 (1.09%)
Rash	9 (1.09%)
Infection	8 (.97%)
Pancytopenia	8 (.97%)
Pneumonia	8 (.97%)
Renal Disorder	8 (.97%)
Renal Failure	8 (.97%)
Headache	7 (.85%)
Hepatic Encephalopathy	7 (.85%)
Hepatic Failure	7 (.85%)
Neuropathy Peripheral	7 (.85%)
Platelet Count Decreased	7 (.85%)
Abortion Missed	6 (.73%)
Anorexia	6 (.73%)
Blood Lactate Dehydrogenase Increas...	6 (.73%)
Dyspnoea	6 (.73%)
Erythema Multiforme	6 (.73%)
Hepatitis Fulminant	6 (.73%)
Quadriplegia	6 (.73%)
Vomiting	6 (.73%)
Agranulocytosis	5 (.61%)
Calculus Urinary	5 (.61%)
Drug Ineffective	5 (.61%)
Epstein-barr Virus Infection	5 (.61%)
Herpes Zoster Disseminated	5 (.61%)
Jaundice	5 (.61%)
Multi-organ Failure	5 (.61%)
Pulmonary Tuberculosis	5 (.61%)
Renal Impairment	5 (.61%)
Spinal Fracture	5 (.61%)
Systemic Lupus Erythematosus	5 (.61%)
Acute Hepatic Failure	4 (.49%)
Anaemia	4 (.49%)
Blood Alkaline Phosphatase Increase...	4 (.49%)
Blood Creatine Phosphokinase Increa...	4 (.49%)
Death	4 (.49%)
Drug Interaction	4 (.49%)
Gamma-glutamyltransferase Increased	4 (.49%)
Hepatitis	4 (.49%)
Hypersensitivity	4 (.49%)
Hypoglycaemia	4 (.49%)
Hyponatraemia	4 (.49%)
Lymphoma	4 (.49%)
Mycobacterium Avium Complex Infecti...	4 (.49%)
Pleural Effusion	4 (.49%)
Renal Failure Acute	4 (.49%)
Respiratory Failure	4 (.49%)
Adverse Drug Reaction	3 (.36%)
Aplasia Pure Red Cell	3 (.36%)
Arthritis	3 (.36%)
Ascites	3 (.36%)
Blood Bilirubin Increased	3 (.36%)
Blood Pressure Increased	3 (.36%)
Blood Urea Increased	3 (.36%)
C-reactive Protein Increased	3 (.36%)
Chest X-ray Abnormal	3 (.36%)
Chills	3 (.36%)
Cytomegalovirus Viraemia	3 (.36%)
Decreased Appetite	3 (.36%)
Diarrhoea	3 (.36%)
Drug Eruption	3 (.36%)
Drug Exposure During Pregnancy	3 (.36%)
Encephalopathy	3 (.36%)
Enteritis Infectious	3 (.36%)
Foreign Body Trauma	3 (.36%)
Glucose Urine Present	3 (.36%)
Haemodialysis	3 (.36%)
Haemolytic Anaemia	3 (.36%)
Henoch-schonlein Purpura	3 (.36%)
Immunosuppressant Drug Level Decrea...	3 (.36%)
Interstitial Lung Disease	3 (.36%)
Leukopenia	3 (.36%)
Lupus Nephritis	3 (.36%)
Nausea	3 (.36%)
Nephrotic Syndrome	3 (.36%)
Neutrophil Count Decreased	3 (.36%)
Oedema Peripheral	3 (.36%)
Optic Neuritis	3 (.36%)
Ovarian Cancer	3 (.36%)
Peritoneal Tuberculosis	3 (.36%)
Protein-losing Gastroenteropathy	3 (.36%)
Red Blood Cell Count Decreased	3 (.36%)
Rheumatoid Arthritis	3 (.36%)
Rhinorrhoea	3 (.36%)
Scotoma	3 (.36%)
Urinary Tract Infection	3 (.36%)
Uterine Cancer	3 (.36%)
Weight Increased	3 (.36%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Iscotin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Iscotin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Iscotin

What are the most common Iscotin adverse events reported to the FDA?

Hepatic And Hepatobiliary	90 (10.95%)
Infections - Pathogen Unspecified	49 (5.96%)
Hepatobiliary	46 (5.6%)
Hematology Investigations	33 (4.01%)
Viral Infectious	33 (4.01%)
Renal Disorders	28 (3.41%)
Epidermal And Dermal Conditions	27 (3.28%)
Respiratory	22 (2.68%)
Mycobacterial Infectious	19 (2.31%)
Anemias Nonhemolytic And Marrow Dep...	17 (2.07%)
Coagulopathies And Bleeding Diathes...	17 (2.07%)
	Show More
Fungal Infectious	16 (1.95%)
Enzyme	15 (1.82%)
Neurological	14 (1.7%)
Therapeutic And Nontherapeutic Effe...	12 (1.46%)
Bacterial Infectious	11 (1.34%)
Gastrointestinal Signs	11 (1.34%)
Nephropathies	11 (1.34%)
White Blood Cell	11 (1.34%)
Appetite And General Nutritional	10 (1.22%)
Body Temperature Conditions	10 (1.22%)
Encephalopathies	10 (1.22%)
Lower Respiratory Tract Disorders	10 (1.22%)
Renal And Urinary Tract Investigati...	9 (1.09%)
Central Nervous System Vascular	8 (.97%)
Electrolyte And Fluid Balance Condi...	8 (.97%)
Movement Disorders	8 (.97%)
Headaches	7 (.85%)
Joint	7 (.85%)
Peripheral Neuropathies	7 (.85%)
Abortions And Stillbirth	6 (.73%)
Bone And Joint Injuries	6 (.73%)
Reproductive Neoplasms Female Malig...	6 (.73%)
Skin Vascular Abnormalities	6 (.73%)
Cardiac And Vascular Investigations	5 (.61%)
Chemical Injury And Poisoning	5 (.61%)
Connective Tissue Disorders	5 (.61%)
Cranial Nerve Disorders	5 (.61%)
Fatal Outcomes	5 (.61%)
Glucose Metabolism Disorders	5 (.61%)
Injuries	5 (.61%)
Muscle	5 (.61%)
Pleural	5 (.61%)
Urolithiases	5 (.61%)
Allergic Conditions	4 (.49%)
Disturbances In Thinking	4 (.49%)
Gastrointestinal Conditions	4 (.49%)
Hematological And Lymphoid Tissue T...	4 (.49%)
Hemolyses And Related Conditions	4 (.49%)
Immune	4 (.49%)
Lymphomas	4 (.49%)
Physical Examination Topics	4 (.49%)
Protein And Chemistry Analyses	4 (.49%)
Vision	4 (.49%)
Water, Electrolyte And Mineral	4 (.49%)
Deliria	3 (.36%)
Gastrointestinal Motility And Defec...	3 (.36%)
Immunology And Allergy	3 (.36%)
Lipid Metabolism	3 (.36%)
Peritoneal And Retroperitoneal Cond...	3 (.36%)
Respiratory And Pulmonary Investiga...	3 (.36%)
Spleen, Lymphatic And Reticulendoth...	3 (.36%)
Toxicology And Therapeutic Drug Mon...	3 (.36%)
Aural	2 (.24%)
Changes In Physical Activity	2 (.24%)
Communication Disorders	2 (.24%)
Depressed Mood Disorders	2 (.24%)
Gallbladder	2 (.24%)
Hearing	2 (.24%)
Hypothalamus And Pituitary Gland	2 (.24%)
Iron And Trace Metal Metabolism	2 (.24%)
Lifestyle Issues	2 (.24%)
Medication Errors	2 (.24%)
Microbiology And Serology	2 (.24%)
Ocular Neuromuscular	2 (.24%)
Pregnancy, Labour, Delivery And Pos...	2 (.24%)
Purine And Pyrimidine Metabolism	2 (.24%)
Acid-base	1 (.12%)
Angiedema And Urticaria	1 (.12%)
Anterior Eye Structural Change, Dep...	1 (.12%)
Arteriosclerosis, Stenosis, Vascula...	1 (.12%)
Bile Duct	1 (.12%)
Cardiac Disorder Signs	1 (.12%)
Congenital And Hereditary	1 (.12%)
Demyelinating	1 (.12%)
Environmental Issues	1 (.12%)
Gastrointestinal Inflammatory Condi...	1 (.12%)
Gastrointestinal Ulceration And Per...	1 (.12%)
Hematopoietic Neoplasms	1 (.12%)
Immunodeficiency Syndromes	1 (.12%)
Lymphomas Non-hodgkins B-cell	1 (.12%)
Metabolic, Nutritional And Blood Ga...	1 (.12%)
Musculoskeletal And Connective Tiss...	1 (.12%)
Ocular Sensory Symptoms	1 (.12%)
Ocular Structural Change, Deposit A...	1 (.12%)
Oral Soft Tissue Conditions	1 (.12%)
Platelet	1 (.12%)
Procedural And Device Related Injur...	1 (.12%)
Renal And Urinary Tract Disorders C...	1 (.12%)
Respiratory And Mediastinal Neoplas...	1 (.12%)
Seizures	1 (.12%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Iscotin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Iscotin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.